Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma

Abstract excerpt

Glioblastoma, also known as glioblastoma multiforme, is the most common and worldwide-spread cancer that begins within the brain. Glioblastomas represent 15% of brain tumors. The most common length of survival following diagnosis is 12 to 14 months with less than 3% to 5% of people surviving longer than five years. Without treatment, survival is typically 3 months. Among all receptors, special attention has been...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammatory mediators and NSAID effects
• Share to Metabolism, Diabetes, and Cancer
• Share to Peroxisome Proliferator-Activated Receptors